Lakewood-Amedex appoints biotech veteran Dr. Joseph Tucker to Board of Directors

Filed April 28, 2026 · Period ending April 24, 2026 · ~1 min read

Key Changes

• medium

  Dr. Joseph Tucker, CEO of Enveric Biosciences with experience raising $100M+ and executing IPOs and M&A, joins LABT's Board effective April 24, 2026. He will serve on Finance, Audit, Compensation, and Governance committees until the 2027 annual meeting.

  Item 5.02 verify on EDGAR →
• low

  Tucker receives $6,000 quarterly compensation paid in common stock shares, plus 33,784 warrants exercisable at $10.00 per share with 10-year term, vesting quarterly over two years in four equal tranches of 8,446 warrants each.

  Item 5.02 verify on EDGAR →
• low

  Board Agreement requires Tucker to attend 2-4 Board meetings annually and be available for ad-hoc consultations, with reimbursement for pre-approved travel expenses. Agreement continues indefinitely unless terminated by either party.

  Item 5.02 verify on EDGAR →